Juliesta advises Health-Tech companies on M&A and strategic financing transactions.
Prior to joining WCP, Juliesta was Head of the Global Data and Innovation divisions at Diaceutics, where she built, priced, and brought to market a suite of data products and analytical services that transformed the privately-owned consulting company into a publicly traded technology company on the LSE. She brings 20 years of combined experience brokering healthcare data transactions, leading data analytics startups, and partnering with top-10 biotechnology and pharmaceutical companies on intellectual property and product development. Juliesta has deep expertise in diagnostic and genomics technologies.
Some of the product developments that Juliesta led include a cloud-based, HIPAA- and GDPR-compliant clinical data platform for Pharma, a multi-omics integration SaaS for providers, a statistical confidence tool for diagnostics, high-throughput drug development screens, and R&D partnerships with Janssen, Merck, Luminex, and SoluLink. For 7 years, Juliesta has also co-invested with Beacon Value Partners in Cambridge, MA.
Juliesta has a B.A. and Ph.D. in Biochemistry and Molecular Biology, both from the University of Chicago. Her postdoctoral projects were at the Massachusetts Institute of Technology (MIT) and The Scripps Research Institute (TSRI).
Digital Health
Thank you! We will send the link to download the full report to the email you provided. If you have any questions please email kelly.porter@woodsidecap.com
There was an error trying to send your message. Please try again later.